Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 4 | $105,541 |
| Sells | 8 | $1,932,733 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 15 Oct 2024 16:21 | MLYS | Mineralys Therapeutics Inc | CONGLETON JON | Chief Executive Officer | 11 Oct 2024 | Sale | 15,271 | 13.518 | 206,433 | D |
| 12 Jul 2024 16:36 | MLYS | Mineralys Therapeutics Inc | CONGLETON JON | Chief Executive Officer | 11 Jul 2024 | Sale | 15,746 | 13.3415 | 210,075 | D |
| 20 Jun 2024 17:44 | MLYS | Mineralys Therapeutics Inc | CONGLETON JON | Chief Executive Officer | 20 Jun 2024 | Sale | 14,940 | 11.7294 | 175,237 | D |
| 20 Jun 2024 17:44 | MLYS | Mineralys Therapeutics Inc | CONGLETON JON | Chief Executive Officer | 18 Jun 2024 | Sale | 16,607 | 11.9873 | 199,073 | D |
| 20 Jun 2024 17:44 | MLYS | Mineralys Therapeutics Inc | CONGLETON JON | Chief Executive Officer | 17 Jun 2024 | Sale | 17,766 | 12.2544 | 217,712 | D |
| 14 Jun 2024 18:15 | MLYS | Mineralys Therapeutics Inc | CONGLETON JON | Chief Executive Officer | 14 Jun 2024 | Sale | 16,229 | 12.5185 | 203,163 | D |
| 14 Jun 2024 18:15 | MLYS | Mineralys Therapeutics Inc | CONGLETON JON | Chief Executive Officer | 13 Jun 2024 | Sale | 39,961 | 12.7381 | 509,027 | D |
| 14 Jun 2024 18:15 | MLYS | Mineralys Therapeutics Inc | CONGLETON JON | Chief Executive Officer | 12 Jun 2024 | Sale | 16,607 | 12.7665 | 212,013 | D |
| 27 Nov 2023 16:01 | MLYS | Mineralys Therapeutics Inc | CONGLETON JON | Chief Executive Officer | 22 Nov 2023 | Purchase | 4,250 | 5.9661 | 25,356 | D |
| 08 Sep 2023 08:49 | MLYS | Mineralys Therapeutics Inc | CONGLETON JON | Chief Executive Officer | 06 Sep 2023 | Purchase | 2,250 | 12.08 | 27,180 | D |
| 21 Aug 2023 16:03 | MLYS | Mineralys Therapeutics Inc | CONGLETON JON | Chief Executive Officer | 17 Aug 2023 | Purchase | 2,250 | 12.1 | 27,225 | D |
| 11 Aug 2023 19:11 | MLYS | Mineralys Therapeutics Inc | CONGLETON JON | Chief Executive Officer | 11 Aug 2023 | Purchase | 2,000 | 12.89 | 25,780 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)